NobleStitch EL
Commercial- Indications
- Patent foramen ovale, Ischemic stroke
Company intelligence / Profile preview
Nobles Medical Technologies II’s lead product, NobleStitch EL, is a suture-based catheter system designed to close patent foramen ovale (PFO) without leaving a permanent implant. It has been used successfully in Europe and received significant interest from clinicians globally. In the US it holds FDA clearance as a vascular/cardiovascular suturing device but not specifically indicated for blind PFO closure. Clinical studies have shown positive outcomes with over 100 cases presented at major cardiology conferences[6][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nobles Medical Technologies.